The first OTC COVID-19 test authorized through the Food and Drug Administration’s premarket review pathway, not on an emergency waiver, also is the first at-home test for any respiratory illness the agency authorized using its traditional evaluation process.
The FDA’s first premarket approval of an OTC test for any respiratory illness went to the first firm to receive an emergency use authorization for an at-home molecular COVID-19 test,...